DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate
The clinical trials for the vaccine are likely to start before the year ends
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.